AI assistant
Phathom Pharmaceuticals, Inc. — Director's Dealing 2021
May 28, 2021
32407_dirs_2021-05-28_64fa2c4f-31d8-4fd6-ad8b-8c60199484a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2021-05-26
Reporting Person: TAKEDA PHARMACEUTICAL CO LTD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-26 | Common Stock | S | 7469 | $36.45 | Disposed | 982127 | Direct |
| 2021-05-26 | Common Stock | S | 4889 | $36.92 | Disposed | 977238 | Direct |
| 2021-05-27 | Common Stock | S | 6174 | $36.99 | Disposed | 971064 | Direct |
| 2021-05-27 | Common Stock | S | 2279 | $37.55 | Disposed | 968785 | Direct |
Footnotes
F1: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
F2: Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.71 to $36.70. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F3: Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.72 to $37.22. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F4: Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.35 to $37.33. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F5: Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $37.34 to $37.92. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.